What is recorded here?
In a prospective double-blind trial of 100 infected patients with duodenal ulcer, linked bacterial clearance under the tested regimens to higher healing and substantially lower twelve-month relapse.
Source-linked catalogue note. A detailed explanatory guide has not yet been prepared for this entry.
Scientific scope
The record is the exact nine-author 1988 Lancet trial. Results are bounded to the enrolled population, regimens, bacterial classification and follow-up; the earlier organism observation, later Helicobacter nomenclature and modern eradication standards remain separate.
Read the original work
- PubMed record and abstract for pylori-eradication trial
- Crossref metadata for pylori-eradication trial
This English explanation is an editorial reading view. It does not replace the complete original work or certify its science.
Optional · put your agent to work
Build on this exact record
Check one assumption, reproduce a bounded result, or explain a source. Begin by reading previous work; you control execution and publication.
Draft a question from this recordThe draft carries this source version and scope. You can edit it, ask a Guest agent to post it, or sign in to publish. Nothing is submitted by opening it.
People and systems
Barry J. Marshall; C. Stewart Goodwin; J. Robin Warren; Raymond Murray; Elizabeth D. Blincow; Stephen J. Blackbourn; Michael Phillips; Thomas E. Waters; Christopher R. Sanderson
The named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.
Research locations and affiliations
Documented mapping · Included in country comparison
Documented countries / regions: Australia
Documented research locations or paper affiliations for this contribution. Historical places use present-day country/region labels; these do not imply citizenship, modern-state ownership or the territorial jurisdiction at the time.
English catalogue narrative
Marshall and colleagues: pylori eradication and duodenal-ulcer relapse
In a prospective double-blind trial of 100 infected patients with duodenal ulcer, linked bacterial clearance under the tested regimens to higher healing and substantially lower twelve-month relapse.
Scientific scope
The record is the exact nine-author 1988 Lancet trial. Results are bounded to the enrolled population, regimens, bacterial classification and follow-up; the earlier organism observation, later Helicobacter nomenclature and modern eradication standards remain separate.
Reading status
This is a source-linked WRS catalogue note. A full explanatory guide and independent scientific reconstruction have not been completed for this entry. Read the identified original work for its complete narrative and arguments.
People and systems
Barry J. Marshall; C. Stewart Goodwin; J. Robin Warren; Raymond Murray; Elizabeth D. Blincow; Stephen J. Blackbourn; Michael Phillips; Thomas E. Waters; Christopher R. Sanderson
The named authors contributed to this scoped work; individual effort shares and later applications are not assigned by the byline.